Agilon Health
97 hedge funds and large institutions have $122M invested in Agilon Health in 2026 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 45 increasing their positions, 24 reducing their positions, and 107 closing their positions.
3,517% more call options, than puts
Call options by funds: $5.68M | Put options by funds: $157K
88% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 24
0.09% more ownership
Funds ownership: 3.64% → 3.73% (+0.09%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
50% less funds holding
Funds holding: 194 → 97 (-97)
53% less capital invested
Capital invested by funds: $260M → $122M (-$138M)
87% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 107
Top Buyers
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
+$9.16M |
| 2 |
Goldman Sachs
New York
|
+$4.2M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.38M |
| 4 |
EP
Eversept Partners
New York
|
+$2.86M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$2.18M |
Top Sellers
| 1 |
Capital World Investors
Los Angeles,
California
|
-$5.76M |
| 2 |
CP
CenterBook Partners
Greenwich,
Connecticut
|
-$4.84M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.8M |
| 4 |
Amundi
Paris,
France
|
-$1.36M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.26M |
AGL Hedge Fund Activity: Q1 2026 in Review
97 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Agilon Health (AGL) for Q1 2026, worth a combined $122M — down 53% from $260M a quarter earlier.
Sellers outnumbered buyers: 107 funds closed out of AGL and 14 opened new positions — a net loss of 93 holders — while 24 trimmed existing stakes and 45 added.
The largest buyer was AQR Capital Management, adding an estimated $9.16M. The largest seller was Capital World Investors, exiting entirely with an estimated $5.76M sold.
- 97 institutional investors held Agilon Health (AGL) as of Q1 2026, down from 194 in Q4 2025.
- Funds reported $122M of Agilon Health stock for Q1 2026, down 53% quarter-over-quarter.
- 14 funds opened new Agilon Health positions in Q1 2026 and 107 closed out, a net change of -93 holders.
- The largest Agilon Health buyer in Q1 2026 was AQR Capital Management, an estimated $9.16M added.
- The largest Agilon Health seller in Q1 2026 was Capital World Investors, an estimated $5.76M sold.
Based on aggregated 13F filings for Q1 2026.